Wilson’s disease, an autosomal recessive disorder of copper metabolism, is caused by about 200 different mutations of the ATP7B gene. Using a genotype-phenotype correlation, 36 patients were examined to see whether the disorder of the automatic handwriting movement depends on the genotype. The findings of this study indicated that no such link exists. Neither the profile of the impairment of the fine motor parameters nor the severity and frequency of pathological findings were different among the three genotype groups (homozygous for H1069Q, compound homozygous for H1069Q and other mutations). By contrast, fine motor disorders were found to correlate with the clinical symptoms recorded when therapy began. The pathophysiology of the basal ganglia and the cerebellar loop therefore cannot be directly attributed to the genotype of the mutation in the ATP7B gene.

1.
Maier-Dobersberger T: Morbus Wilson. Diagnosestellung mit konventionellen und molekularbiologischen Methoden. Dtsch Med Wochenschr 1999;124:493–496.
2.
Cuthbert JA: Wilson’s disease: A new gene and an animal model for an old disease. J Investig Med 1995;43:323–336.
3.
Frydman M, Bonne-Tamir B, Farrer LA, Conneally PM, Magazanik A, Ashbel S, Goldwitch Z: Assignment of the gene for Wilson disease to chromosome 13: Linkage to the esterase D locus. Proc Natl Acad Sci USA 1985;82:1819–1821.
4.
Bowcock AM, Farrer LA, Hebert JM, Agger M, Sternlieb I, Scheinberg IH, Buys CH, Scheffer H, Frydman M, Chajek-Saul T, Bonne-Tamir B, Cavalli-Sforza LL: Eight closely linked loci place the Wilson disease locus within 13q14–q21. Am J Hum Genet 1988;43:664–674.
5.
Kenney S, Cox DW: The Wilson Disease Database; Copyright© 1999–2002 University of Alberta; last updated February 14, 2002 (http://www.medgen.med.ualberta.ca/database.html).
6.
Ferenci P: Wilson’s disease. Ital J Gastroenterol Hepatol 1999;31:416–425.
7.
Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, Parano E, Pavone L, Evgrafov O, Ivanova-Smolenskya IA, Anneren G, Westermark K, Urrutia FH, Penchaszadeh GK, Sternlieb I, Scheinberg IH, Gilliam TC, Petrukhin K: Identification and analysis of mutations in the Wilson disease gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997;61:317–328.
8.
Maier-Dobersberger T, Ferenci P, Polli C, Balac P, Dienes HP, Kaserer K, Datz C, Vogel W, Gangl A: Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med 1997;127:21–26.
9.
Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW: The Wilson disease gene: Spectrum of mutations and their consequences. Nat Genet 1995;9:210–217.
10.
Houwen RH, Juyn J, Hoogenraad TU, Ploos van Amstel JK, Berger R: H714Q mutation in Wilson disease is associated with late neurological presentation. J Med Genet 1995;32:480–482.
11.
Czlonkowska A, Rodo M, Gajda J, Ploos van Amstel HK, Juyn J, Houwen RHJ: Very high frequency of the His1069Gln mutation in Polish Wilson disease patients. J Neurol 1997;244:591–592.
12.
Schöls L, Riess O: Kupferstoffwechselstörungen; in Riess O, Schöls L (eds): Neurogenetik. Berlin, Springer, 1998, pp 218–222.
13.
Cox DW, Thomas GR, Roberts EA, Walshe JM: The Wilson disease gene: Clinical implications. Hepatology 1994;20:267.
14.
Gollan JL, Gollan TJ: Wilson disease in 1998:Genetic, diagnostic and therapeutic aspects. J Hepatol 1998;28(suppl 1):28–36.
15.
Mai N, Marquardt C: Computergestützte Analyse der Bewegungsabläufe beim Schreiben; Bedienungsanleitung 4.2. München, Med Com, 1994.
16.
Hollerbach JM: An oscillation theory of handwriting. Biol Cybern 1981;39:139–156.
17.
Mai N, Marquardt C: EKN-Materialien für die Rehabilitation. Schreibtraining in der neurologischen Rehabilitation. Dortmund, Borgmann, 1995.
18.
Flash T, Hogan N: The coordination of arm movements: An experimentally confirmed mathematical model. J Neurosci 1985;5:1688–1703.
19.
Mai N, Marquardt C: Analyse und Therapie motorischer Schreibstörungen. Psychol Beitr 1995;37:538–582.
20.
del Rosario MAF, Davis MM, Chong SKF: Wobbly handwriting. Lancet 1998;351:336.
21.
Eichhorn TE, Gasser T, Mai N, Marquardt C, Arnold G, Schwarz J, Oertel WH: Computational analysis of open loop handwriting movements in Parkinson’s disease: A rapid method to detect dopamimetic effects. Mov Disord 1996;11:289–297.
22.
Kömpf D, Wessel K: Funktion und Symptomatik einzelner Hirnregionen; in Hopf HC, Deuschl G, Diener HC, Reichmann H (eds): Neurologie in Praxis und Klinik, ed 3. Stuttgart, Thieme, 1999, vol 1, pp 1–37.
23.
Conrad B: Pathophysiologie der Bewegungsstörungen; in Conrad B, Ceballos-Baumann O (eds): Bewegungsstörungen in der Neurologie. Stuttgart, Thieme, 1996, pp 11–29.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.